Sign in
4

Changes in Ownership

Syndax Pharmaceuticals Inc Filed Acc 0001562180-21-007710

President and COO sold 36,609 shares at $19.05 ($697,519)

  • President and COO acquired 36,609 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Metzger Michael A · President and COO

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2021-12-13 Exercise or conversion : show line 1 in the form +2,045 $7.20 $14,724 19,704 D
2021-12-13 Sale : show line 2 in the form −2,045 $19.05 $38,964 17,659 D
2021-12-13 Exercise or conversion : show line 3 in the form +34,564 $6.38 $220,518 52,223 D
2021-12-13 Sale : show line 4 in the form −34,564 $19.05 $658,555 17,659 D
Open-market sales · 36,609 sh · avg $19.05 · $697,519

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2021-12-13 Exercise or conversion : show line 5 in the form Stock Options (Right to buy) −2,045 0 D
2021-12-13 Exercise or conversion : show line 6 in the form Stock Options (Right to buy) −34,564 0 D
Loading xslF345X03/primarydocument.xml…